Matthias Heldwein

University of Cologne

Papers

1

Total Citations

3

H-Index

1

About

Matthias Heldwein is a clinical researcher whose work focuses on the surgical management of myasthenia gravis, particularly the role of thymectomy in non-thymomatous cases. His most-cited paper, "Der Stellenwert der Thymektomie ohne Thymom in der Therapie der Myasthenia gravis" (2021), addresses a long-standing controversy in neuromuscular surgery: whether thymus removal benefits patients without thymoma. By synthesizing evidence from studies with inconsistent documentation and long follow-up periods, Heldwein clarifies the therapeutic value of this procedure, offering guidance for surgeons and neurologists. Though his citation count is modest (3 citations), his work contributes to a nuanced understanding of surgical outcomes in a rare disease. Heldwein’s research underscores the challenges of studying low-incidence conditions and the importance of rigorous, long-term data. For students and researchers in thoracic surgery or neurology, his work highlights the need for careful patient selection and evidence-based decision-making in myasthenia gravis treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Der Stellenwert der Thymektomie ohne Thymom in der Therapie der Myasthenia gravis
3 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Cologne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago